Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protalix BioTherapeutics (PLX) Shares Issued (2016 - 2025)

Protalix BioTherapeutics (PLX) has 10 years of Shares Issued data on record, last reported at $4.0 million in Q2 2025.

  • For Q2 2025, Shares Issued changed N/A year-over-year to $4.0 million; the TTM value through Sep 2025 reached $30.1 million, changed N/A, while the annual FY2024 figure was $3.6 million, 84.86% down from the prior year.
  • Shares Issued reached $4.0 million in Q2 2025 per PLX's latest filing, up from $2.9 million in the prior quarter.
  • Across five years, Shares Issued topped out at $23.2 million in Q4 2023 and bottomed at -$19.3 million in Q2 2023.
  • Average Shares Issued over 4 years is $5.2 million, with a median of $4.0 million recorded in 2025.